Tricyclic Antidepressants Inhibit Voltage-dependent Calcium Channels and Na(+)-Ca2+ Exchange in Rat Brain Cortex Synaptosomes
Overview
Physiology
Authors
Affiliations
We have used a resting (5 mM K+) or depolarizing (60 mM K+) choline-based medium, and a nondepolarizing sodium-based or choline-based medium, to characterize the inhibitory potential of tricyclic antidepressants against the voltage-dependent calcium channels or the Na(+)-Ca2+ exchange process, respectively, in synaptosomes from rat brain cortex. Imipramine, desipramine, amitriptyline, and clomipramine inhibited net K(+)-induced 45Ca uptake with similar IC50 values (26-31 microM), and this uptake was also inhibited by diltiazem with an IC50 of 36 microM; these results indicate an inhibition of voltage-dependent calcium channels by tricyclic antidepressants. The net uptake of 45Ca induced by Na(+)-Ca2+ exchange was also inhibited by the four tricyclic antidepressants tested, but not by diltiazem; imipramine (IC50 = 94 microM) was a more potent inhibitor of this process than desipramine (IC50 = 151 microM), and the IC50 values of amitriptyline (107 microM) and clomipramine (97 microM) were similar to that of imipramine. Some degree (approximately 25%) of brain calcium channel blockade could be present at the steady-state concentrations of tricyclic antidepressants expected to occur therapeutic use of these compounds to treat depression or panic disorder.
Therapeutic potential of orally applied KB-R7943 in streptozotocin-induced neuropathy in rats.
Andreeva-Gateva P, Hristov M, Strokova-Stoilova M, Ivanova N, Sabit Z, Surcheva S Heliyon. 2024; 10(6):e27367.
PMID: 38524546 PMC: 10958225. DOI: 10.1016/j.heliyon.2024.e27367.
Boikov S, Sibarov D, Stepanenko Y, Karelina T, Antonov S Int J Mol Sci. 2022; 23(24).
PMID: 36555818 PMC: 9787943. DOI: 10.3390/ijms232416177.
Cardoso F, Schmit M, Kuiper M, Lewis R, Tuck K, Duggan P RSC Med Chem. 2022; 13(2):183-195.
PMID: 35308021 PMC: 8864487. DOI: 10.1039/d1md00331c.
Stepanenko Y, Sibarov D, Shestakova N, Antonov S Front Pharmacol. 2022; 12:815368.
PMID: 35237149 PMC: 8882908. DOI: 10.3389/fphar.2021.815368.
Bang E, Tobery A, Montgomery K, Fincher A, Earnest D, Murchison D Front Aging Neurosci. 2021; 13:673155.
PMID: 34122049 PMC: 8193944. DOI: 10.3389/fnagi.2021.673155.